Using a spleen autotransplantation model, we conducted hematological, hemorheological, immunological, and morphological studies in mice 6 weeks after splenectomy. Sixty male and female A/J inbred mice were equally divided into 3 groups: 1) SE group, splenectomy was performed; 2) AU group, spleen chips were autotransplanted into the omentum without vascular anastomosis following splenectomy; and 3) C group (controls), no intervention in these mice. At postoperative week 6, the following studies were performed: 1) measurement of hematological parameters; 2) hemorheological studies, including relative cell transit time (RCTT) and fibrinogen levels; and 3) activity of peripheral phagocytes, measured by zymozan-induced chemiluminescence, which was calculated in stimulation index values (SI). In addition, histological investigations of autotransplants were conducted. Erythrocyte mean cell volume and platelet counts, RCTT, fibrinogen levels, and activity of phagocytes were significantly higher in the SE group, compared to those in the C group. In the AU group, these parameters were similar to those in the C group. Morphologically, the transplanted spleen showed normal histology. These data indicate that the transplanted spleens restored their function. We conclude that spleen autotransplantation reserves the normal morphology of spleen and restores most of the spleen's hematological, hemorheological, and immunological functions. Both SI index and erythrocyte deformability can be an informative detection of decreasing splenic function. These data suggest that spleen autotransplantation may provide a useful tool to prevent complications following splenectomy in a clinical setting.

Download full-text PDF

Source
http://dx.doi.org/10.1002/micr.10166DOI Listing

Publication Analysis

Top Keywords

spleen autotransplantation
16
hematological hemorheological
12
hemorheological immunological
12
immunological morphological
8
morphological studies
8
rctt fibrinogen
8
fibrinogen levels
8
levels activity
8
spleen
7
group
7

Similar Publications

Influence of Organ-Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B-Cell Lymphoma.

Cancer Med

January 2025

Lymphoma and Cell Therapy Research Center, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Background: The prognostic significance of extranodal sites in stage IV diffuse large B-cell lymphoma (DLBCL) remains uncertain, making it challenging to select appropriate treatment strategies for individual patients. In this study, we aimed to evaluate the influence of different extranodal sites on prognosis in young patients with stage IV DLBCL who achieved complete remission (CR) following initial chemo-immunotherapy and to explore the potential of autologous hematopoietic stem cell transplantation (ASCT) as a consolidation treatment for specific patient subgroups.

Methods: We retrospectively reviewed data from 119 patients with DLBCL aged < 60 years who achieved CR after chemo-immunotherapy between 2008 and 2020.

View Article and Find Full Text PDF

Background: Wandering spleen or hypermobile spleen results from the elongation or maldevelopment of the spleen's suspensory ligaments. Few cases have been reported worldwide, making it a rare clinical entity. It usually affects children, although it also commonly affects female adults in the reproductive age range.

View Article and Find Full Text PDF

[Clinical Characteristics and Prognosis of Patients with Primary Bone Marrow Lymphoma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

August 2024

Department of Hematology, Gansu Provincial Hospital, Lanzhou 730000, Gansu Province, China.

Article Synopsis
  • This study analyzes the characteristics and outcomes of 6 patients diagnosed with primary bone marrow lymphoma from 2011 to 2023 at Gansu Provincial People's Hospital.
  • Patients had a median age of 61, with all presenting symptoms like fever and abnormal blood tests, but no signs of systemic lymphoma in other areas.
  • The prognosis is generally poor, with a median overall survival of 5.5 months, though autologous stem cell transplantation could potentially enhance outcomes.
View Article and Find Full Text PDF

Autosplenectomy in systemic sclerosis.

Clin Rheumatol

October 2024

Department of Medicine, Division of Rheumatology, Queen's University, Kingston, ON, Canada.

View Article and Find Full Text PDF

Background: Enhanced regenerative therapeutic strategies are required to treat intractable ischemic heart disease.

Summary: Since the discovery of putative endothelial progenitor cells (EPCs) in 1997, many studies have focused on their extraction, ex vivo processing, and autotransplantation under ischemic conditions. Nonetheless, numerous randomized clinical trials involving thousands of patients have yielded only marginal treatment effects, highlighting the need for advances regarding insufficient dosage and complex ex vivo processing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!